COV-ENT-1

N/A

Report date: 2024/12/18 13:39:48

NME

Base Information

Drug NameCOV-ENT-1

Drug Alias NameCOV-ENT-1

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionVirus replication inhibitorsVirus internalization inhibitors

TargetsNot applicable

Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusIND

Highest Status in ChinaN/A

Originator CompaniesEnterin Inc

China Registration ClassN/A

Active CompaniesEnterin Inc

Inactive CompaniesN/A

Active IndicationsCoronavirus Disease 2019 (COVID-19)

Inactive IndicationsN/A

ATC CodeN/A